查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1955339

2026年全球椎間關節注射市場報告

Facet-Joint Injection Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，椎間關節注射市場顯著擴張，預計將從2025年的29.7億美元成長到2026年的31.8億美元，複合年成長率為6.9%。過去幾年成長要素包括脊髓退化盛行率的上升、關節炎發生率的增加、疼痛管理意識的提高、皮質類固醇的使用以及門診手術的增加。

預計未來幾年，椎間關節注射市場規模將強勁成長，2030年將達到41億美元，複合年成長率（CAGR）為6.6%。預測期內的成長要素包括人口老化、對微創治療的偏好、慢性疼痛的普遍性、門診治療的成長以及影像導引手術的普及。預測期內的主要趨勢包括：對微創疼痛治療的需求不斷成長、微創治療在慢性背痛管理中的應用日益廣泛、門診疼痛診所的成長、影像引導注射技術的應用以及日間手術中心的擴張。

預計未來幾年，脊椎疾病和慢性背痛的日益普遍將推動椎間關節注射市場的成長。脊椎疾病和慢性背痛是指影響脊椎的長期疾病，例如椎間盤退化、關節炎和神經壓迫，這些疾病會導致持續不適、活動範圍受限和生活品質下降。由於久坐的生活方式和不良姿勢，這些疾病的盛行率正在上升，促使患者尋求有效的非侵入性治療方法來緩解不適並恢復功能性活動。椎間關節注射透過減輕脊椎的發炎和疼痛來幫助控制脊椎疾病和慢性背痛，為受影響的患者提供針對性的緩解。例如，根據美國非營利資訊中心脊髓損傷協會（Spinal Cord Inc.）的數據，截至2023年5月，美國每年報告約18,000例新的脊髓損傷病例，目前全美約有302,000人患有脊髓損傷。因此，脊椎疾病和慢性背痛的日益增加正在推動椎間關節注射市場的成長。

對微創手術需求的不斷成長預計也將推動椎間關節注射市場的成長。微創手術是指切口很小或無需大規模手術切口的醫療程序，因此恢復時間更短，術後疼痛更輕。椎間關節外科醫師協會（總部位於美國的專業組織）報告稱，2023年微創美容手術的總數將從2022年的2370萬例增加到2023年的2540萬例。因此，對微創手術需求的成長正在促進椎間關節注射市場的成長。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球椎間關節注射市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 主要原料、資源和供應商清單
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章 全球市場趨勢與策略

  • 關鍵技術和未來趨勢
    • 生物技術、基因組學和精準醫學
    • 人工智慧（AI）和自主人工智慧
    • 工業4.0和智慧製造
    • 數位化、雲端運算、巨量資料、網路安全
    • 永續性、氣候技術和循環經濟
  • 主要趨勢
    • 對微創疼痛治療方法的需求日益成長
    • 在慢性下背痛管理中應用日益廣泛
    • 門診疼痛診所的成長
    • 採用影像導引注射技術
    • 擴大門診手術中心

第5章 終端用戶產業市場分析

  • 醫院
  • 門診手術中心
  • 專科診所
  • 疼痛管理中心
  • 整形外科診所

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球椎間關節注射市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 全球椎間關節注射市場規模、對比及成長率分析
  • 全球椎間關節注射市場表現：規模與成長，2020-2025年
  • 全球椎間關節注射市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球潛在市場總量（TAM）

第9章 市場細分

  • 依產品類型
  • 皮質類固醇、局部麻醉劑、玻尿酸和其他產品類型
  • 透過使用
  • 椎間關節、胸椎椎間關節、腰椎椎間關節
  • 最終用戶
  • 醫院、門診手術中心、專科診所和其他最終用戶
  • 依類型細分：皮質類固醇
  • 曲安奈德、Methylprednisolone、磷酸地塞米松鈉、Betamethasone
  • 依類型細分：局部麻醉劑
  • Lidocaine、Bupivacaine、Ropivacaine、Prilocaine
  • 按類型細分：透明質酸
  • 高分子量玻尿酸、低分子量玻尿酸、交聯玻尿酸、非交聯玻尿酸
  • 按類型細分：其他產品類型
  • 富血小板血漿、生物製藥及組合產品

第10章 區域與國家分析

  • 全球椎間關節注射市場：依地區、績效及預測分類，2020-2025年、2025-2030年預測、2035年預測
  • 全球椎間關節注射市場：依國家、績效及預測分類，2020-2025年、2025-2030年預測、2035年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 椎間關節注射市場：競爭格局及市場佔有率，2024 年
  • 椎間關節注射市場：公司估值矩陣
  • 椎間關節注射市場：公司簡介
    • Abbott Laboratories
    • B. Braun Melsungen AG
    • BD（Becton Dickinson and Company）
    • Cook Medical
    • Teleflex Incorporated

第37章：其他領先和創新企業

  • Merit Medical Systems Inc., Halyard Health, ICU Medical Inc., Pajunk GmbH Medizintechnologie, Avanos Medical Inc., Vygon SA, Cardinal Health Inc., Terumo Corporation, Nipro Corporation, Septodont Holding, Fresenius Kabi AG, Hikma Pharmaceuticals PLC, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Ltd., Zydus Lifesciences Ltd.

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 2030年椎間關節注射市場：提供新機會的國家
  • 2030年椎間關節注射市場：充滿新機會的市場區隔
  • 2030年椎間關節注射市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第41章附錄

簡介目錄
Product Code: PH5MFJIO01_G26Q1

A facet joint injection is a minimally invasive procedure used to diagnose or treat pain from the facet joints, which are small joints connecting each pair of vertebrae in the spine. The injection usually contains a combination of a local anesthetic, to numb the area, and a corticosteroid, to reduce inflammation. It is commonly employed to relieve chronic neck, back, or thoracic pain caused by arthritis or spinal degeneration.

The main types of facet joint injections include corticosteroids, local anesthetics, hyaluronic acid, and others. Corticosteroids are steroid hormones used to reduce inflammation and suppress the immune system. Applications include cervical, thoracic, and lumbar facet joints, as well as general facet joint injections. These injections are used by end-users such as hospitals, ambulatory surgical centers, specialty clinics, and others.

Tariffs have raised costs in the facet-joint injection market by impacting imports of corticosteroids, hyaluronic acid, anesthetics, and sterile injection devices. Lumbar and cervical facet joint procedures are most affected, particularly in North America and Asia-Pacific where many injectable materials are imported. Hospitals and specialty clinics face rising procedure costs. Positively, tariffs are promoting local manufacturing of injectable drugs and interventional pain management supplies.

The facet-joint injection market research report is one of a series of new reports from The Business Research Company that provides facet-joint injection market statistics, including facet-joint injection industry global market size, regional shares, competitors with a facet-joint injection market share, detailed facet-joint injection market segments, market trends and opportunities, and any further data you may need to thrive in the facet-joint injection industry. This facet-joint injection market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The facet-joint injection market size has grown strongly in recent years. It will grow from $2.97 billion in 2025 to $3.18 billion in 2026 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to spinal degeneration prevalence, arthritis incidence, pain management awareness, corticosteroid use, outpatient procedure growth.

The facet-joint injection market size is expected to see strong growth in the next few years. It will grow to $4.1 billion in 2030 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to aging population, minimally invasive preference, chronic pain prevalence, ambulatory care expansion, imaging-guided procedures. Major trends in the forecast period include rising demand for minimally invasive pain procedures, increased use in chronic back pain management, growth of outpatient pain clinics, adoption of image-guided injection techniques, expansion of ambulatory surgical centers.

The rising prevalence of spinal diseases and chronic back pain is expected to drive the growth of the facet-joint injection market in the coming years. Spinal diseases and chronic back pain refer to long-term conditions affecting the spine, including disc degeneration, arthritis, and nerve compression, which lead to persistent discomfort, limited mobility, and reduced quality of life. The prevalence of these conditions is increasing due to sedentary lifestyles and poor posture habits, prompting individuals to seek effective, minimally disruptive treatments that relieve discomfort and restore functional movement. Facet-joint injections help manage spinal diseases and chronic back pain by reducing inflammation and pain in the spine, providing targeted relief for affected individuals. For instance, in May 2023, according to Spinal Cord Inc., a US-based non-profit resource center, approximately 18,000 new spinal cord injury cases are reported annually in the United States, with an estimated 302,000 individuals currently living with spinal cord injuries nationwide. Therefore, the rising prevalence of spinal diseases and chronic back pain is driving the growth of the facet-joint injection market.

The growing demand for minimally invasive procedures is also expected to support the growth of the facet-joint injection market. Minimally invasive procedures are medical interventions performed through small incisions or without extensive surgical cuts, offering faster recovery times and reduced post-operative pain. Facet-joint injections complement minimally invasive procedures by delivering precise pain relief and diagnostic accuracy without requiring major surgery. For instance, in 2023, the American Society of Plastic Surgeons, a US-based specialty organization, reported that the total number of minimally invasive cosmetic procedures increased from 23.7 million in 2022 to 25.4 million in 2023. Therefore, the rising demand for minimally invasive procedures is contributing to the growth of the facet-joint injection market.

Major companies in the facet-joint injection market are focusing on developing innovative products, such as facet fusion systems, to provide longer-lasting relief and improve treatment outcomes. Facet fusion systems are medical devices designed to stabilize and fuse the facet joints of the spine by promoting bone growth between adjacent vertebrae. For instance, in March 2025, Aurora Spine Corporation, a US-based medical device company, announced that its AEROTM Facet Fusion System received 510(k) clearance from the U.S. Food and Drug Administration (FDA). The system integrates titanium plasma spray coating to enhance osseointegration and fusion potential, supports multiple implant sizes to accommodate varied patient anatomies, and offers radiolucent instrumentation to improve intraoperative visibility. These features collectively aim to enhance procedural efficiency and long-term outcomes in treating chronic back pain caused by facet joint disorders.

Major companies operating in the facet-joint injection market are Abbott Laboratories, B. Braun Melsungen AG, BD (Becton Dickinson and Company), Cook Medical, Teleflex Incorporated, Merit Medical Systems Inc., Halyard Health, ICU Medical Inc., Pajunk GmbH Medizintechnologie, Avanos Medical Inc., Vygon SA, Cardinal Health Inc., Terumo Corporation, Nipro Corporation, Septodont Holding, Fresenius Kabi AG, Hikma Pharmaceuticals PLC, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Ltd., Zydus Lifesciences Ltd., Amneal Pharmaceuticals LLC, Lupin Limited, Piramal Pharma Limited, Intas Pharmaceuticals Ltd., Gland Pharma Limited, Amphastar Pharmaceuticals Inc., Fresenius Medical Care, Baxter International Inc., McKesson Corporation

North America was the largest region in the facet-joint injection market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the facet-joint injection market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the facet-joint injection market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The facet-joint injection market consists of revenues earned by entities through medication management, rehabilitation and psychological counseling, and interventional procedures. The market value includes the value of related goods sold by the service provider or included within the service offering. The facet-joint injection market also includes of sales of injection kits, imaging guidance systems, patient monitoring devices, and pain-relieving medications. Values in this market are 'factory gate' values, meaning the value of goods sold by the manufacturers or creators, whether to other companies (like distributors, clinics, and hospitals) or directly to end users. The value of goods in this market also includes related services provided by the creators, such as training or support for the use of injection products.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Facet-Joint Injection Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses facet-joint injection market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for facet-joint injection ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The facet-joint injection market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product Type: Corticosteroids; Local Anesthetics; Hyaluronic Acid; Other Product Types
  • 2) By Application: Cervical Facet Joints; Thoracic Facet Joints; Lumbar Facet Joints
  • 3) By End-User: Hospitals; Ambulatory Surgical Centers; Specialty Clinics; Other End-Users
  • Subsegments:
  • 1) By Corticosteroids: Triamcinolone Acetonide; Methylprednisolone Acetate; Dexamethasone Sodium Phosphate; Betamethasone
  • 2) By Local Anesthetics: Lidocaine; Bupivacaine; Ropivacaine; Prilocaine
  • 3) By Hyaluronic Acid: High Molecular Weight Hyaluronic Acid; Low Molecular Weight Hyaluronic Acid; Cross-Linked Hyaluronic Acid; Non-Cross-Linked Hyaluronic Acid
  • 4) By Other Product Types: Platelet-Rich Plasma; Biological Agents; Combination Formulations
  • Companies Mentioned: Abbott Laboratories; B. Braun Melsungen AG; BD (Becton Dickinson and Company); Cook Medical; Teleflex Incorporated; Merit Medical Systems Inc.; Halyard Health; ICU Medical Inc.; Pajunk GmbH Medizintechnologie; Avanos Medical Inc.; Vygon SA; Cardinal Health Inc.; Terumo Corporation; Nipro Corporation; Septodont Holding; Fresenius Kabi AG; Hikma Pharmaceuticals PLC; Sun Pharmaceutical Industries Ltd.; Aurobindo Pharma Ltd.; Zydus Lifesciences Ltd.; Amneal Pharmaceuticals LLC; Lupin Limited; Piramal Pharma Limited; Intas Pharmaceuticals Ltd.; Gland Pharma Limited; Amphastar Pharmaceuticals Inc.; Fresenius Medical Care; Baxter International Inc.; McKesson Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Facet-Joint Injection Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Facet-Joint Injection Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Facet-Joint Injection Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Facet-Joint Injection Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Artificial Intelligence & Autonomous Intelligence
    • 4.1.3 Industry 4.0 & Intelligent Manufacturing
    • 4.1.4 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.5 Sustainability, Climate Tech & Circular Economy
  • 4.2. Major Trends
    • 4.2.1 Rising Demand For Minimally Invasive Pain Procedures
    • 4.2.2 Increased Use In Chronic Back Pain Management
    • 4.2.3 Growth Of Outpatient Pain Clinics
    • 4.2.4 Adoption Of Image-Guided Injection Techniques
    • 4.2.5 Expansion Of Ambulatory Surgical Centers

5. Facet-Joint Injection Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Ambulatory Surgical Centers
  • 5.3 Specialty Clinics
  • 5.4 Pain Management Centers
  • 5.5 Orthopedic Clinics

6. Facet-Joint Injection Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Facet-Joint Injection Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Facet-Joint Injection PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Facet-Joint Injection Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Facet-Joint Injection Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Facet-Joint Injection Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Facet-Joint Injection Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Facet-Joint Injection Market Segmentation

  • 9.1. Global Facet-Joint Injection Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Corticosteroids, Local Anesthetics, Hyaluronic Acid, Other Product Types
  • 9.2. Global Facet-Joint Injection Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Cervical Facet Joints, Thoracic Facet Joints, Lumbar Facet Joints
  • 9.3. Global Facet-Joint Injection Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Other End-Users
  • 9.4. Global Facet-Joint Injection Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Triamcinolone Acetonide, Methylprednisolone Acetate, Dexamethasone Sodium Phosphate, Betamethasone
  • 9.5. Global Facet-Joint Injection Market, Sub-Segmentation Of Local Anesthetics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Lidocaine, Bupivacaine, Ropivacaine, Prilocaine
  • 9.6. Global Facet-Joint Injection Market, Sub-Segmentation Of Hyaluronic Acid, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • High Molecular Weight Hyaluronic Acid, Low Molecular Weight Hyaluronic Acid, Cross-Linked Hyaluronic Acid, Non-Cross-Linked Hyaluronic Acid
  • 9.7. Global Facet-Joint Injection Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Platelet-Rich Plasma, Biological Agents, Combination Formulations

10. Facet-Joint Injection Market Regional And Country Analysis

  • 10.1. Global Facet-Joint Injection Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Facet-Joint Injection Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Facet-Joint Injection Market

  • 11.1. Asia-Pacific Facet-Joint Injection Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Facet-Joint Injection Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Facet-Joint Injection Market

  • 12.1. China Facet-Joint Injection Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Facet-Joint Injection Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Facet-Joint Injection Market

  • 13.1. India Facet-Joint Injection Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Facet-Joint Injection Market

  • 14.1. Japan Facet-Joint Injection Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Facet-Joint Injection Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Facet-Joint Injection Market

  • 15.1. Australia Facet-Joint Injection Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Facet-Joint Injection Market

  • 16.1. Indonesia Facet-Joint Injection Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Facet-Joint Injection Market

  • 17.1. South Korea Facet-Joint Injection Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Facet-Joint Injection Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Facet-Joint Injection Market

  • 18.1. Taiwan Facet-Joint Injection Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Facet-Joint Injection Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Facet-Joint Injection Market

  • 19.1. South East Asia Facet-Joint Injection Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Facet-Joint Injection Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Facet-Joint Injection Market

  • 20.1. Western Europe Facet-Joint Injection Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Facet-Joint Injection Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Facet-Joint Injection Market

  • 21.1. UK Facet-Joint Injection Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Facet-Joint Injection Market

  • 22.1. Germany Facet-Joint Injection Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Facet-Joint Injection Market

  • 23.1. France Facet-Joint Injection Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Facet-Joint Injection Market

  • 24.1. Italy Facet-Joint Injection Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Facet-Joint Injection Market

  • 25.1. Spain Facet-Joint Injection Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Facet-Joint Injection Market

  • 26.1. Eastern Europe Facet-Joint Injection Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Facet-Joint Injection Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Facet-Joint Injection Market

  • 27.1. Russia Facet-Joint Injection Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Facet-Joint Injection Market

  • 28.1. North America Facet-Joint Injection Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Facet-Joint Injection Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Facet-Joint Injection Market

  • 29.1. USA Facet-Joint Injection Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Facet-Joint Injection Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Facet-Joint Injection Market

  • 30.1. Canada Facet-Joint Injection Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Facet-Joint Injection Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Facet-Joint Injection Market

  • 31.1. South America Facet-Joint Injection Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Facet-Joint Injection Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Facet-Joint Injection Market

  • 32.1. Brazil Facet-Joint Injection Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Facet-Joint Injection Market

  • 33.1. Middle East Facet-Joint Injection Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Facet-Joint Injection Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Facet-Joint Injection Market

  • 34.1. Africa Facet-Joint Injection Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Facet-Joint Injection Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Facet-Joint Injection Market Regulatory and Investment Landscape

36. Facet-Joint Injection Market Competitive Landscape And Company Profiles

  • 36.1. Facet-Joint Injection Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Facet-Joint Injection Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Facet-Joint Injection Market Company Profiles
    • 36.3.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. B. Braun Melsungen AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. BD (Becton Dickinson and Company) Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Cook Medical Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Teleflex Incorporated Overview, Products and Services, Strategy and Financial Analysis

37. Facet-Joint Injection Market Other Major And Innovative Companies

  • Merit Medical Systems Inc., Halyard Health, ICU Medical Inc., Pajunk GmbH Medizintechnologie, Avanos Medical Inc., Vygon SA, Cardinal Health Inc., Terumo Corporation, Nipro Corporation, Septodont Holding, Fresenius Kabi AG, Hikma Pharmaceuticals PLC, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Ltd., Zydus Lifesciences Ltd.

38. Global Facet-Joint Injection Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Facet-Joint Injection Market

40. Facet-Joint Injection Market High Potential Countries, Segments and Strategies

  • 40.1 Facet-Joint Injection Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Facet-Joint Injection Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Facet-Joint Injection Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer